Apart from that, the impact of ITIH5 on anti-cancer treatment remained elusive although CD44 and distinct splice variants have been intensively studied, highlighting an impact on cellular responsiveness to chemotherapeutics [44]. This evidence concerns the gene CD44 and cancer.